1. Home
  2. GRFS

as of 11-19-2026 3:59pm EST

$8.21
$0.32
-3.75%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Founded: 1940 Country:
Spain
Spain
Employees: N/A City: N/A
Market Cap: 5.2B IPO Year: 2008
Target Price: $10.37 AVG Volume (30 days): 699.5K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
3.24%
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $6.96 - $9.77 Next Earning Date: 07-28-2022
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 2.18% Revenue Growth (next year): 6.15%
P/E Ratio: 18.67 Index: N/A
Free Cash Flow: N/A FCF Growth: -0.61%

Share on Social Networks: